It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mycobacterial cell-wall glycolipids elicit an anti-mycobacterial immune response via FcRγ-associated C-type lectin receptors, including Mincle, and caspase-recruitment domain family member 9 (CARD9). Additionally, mycobacteria harbor immuno-evasive cell-wall lipids associated with virulence and latency; however, a mechanism of action is unclear. Here, we show that the DAP12-associated triggering receptor expressed on myeloid cells 2 (TREM2) recognizes mycobacterial cell-wall mycolic acid (MA)-containing lipids and suggest a mechanism by which mycobacteria control host immunity via TREM2. Macrophages respond to glycosylated MA-containing lipids in a Mincle/FcRγ/CARD9-dependent manner to produce inflammatory cytokines and recruit inducible nitric oxide synthase (iNOS)-positive mycobactericidal macrophages. Conversely, macrophages respond to non-glycosylated MAs in a TREM2/DAP12-dependent but CARD9-independent manner to recruit iNOS-negative mycobacterium-permissive macrophages. Furthermore, TREM2 deletion enhances Mincle-induced macrophage activation in vitro and inflammation in vivo and accelerates the elimination of mycobacterial infection, suggesting that TREM2-DAP12 signaling counteracts Mincle-FcRγ-CARD9-mediated anti-mycobacterial immunity. Mycobacteria, therefore, harness TREM2 for immune evasion.
Mycobacterial cell wall lipids can drive immunoevasion, but underlying mechanisms are incompletely understood. Here the authors show TREM2 is a pattern recognition receptor that binds non-glycosylated mycolic acid-containing lipids and inhibits Mincle-induced anti-mycobacterial macrophage responses.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 Kagoshima University, Department of Immunology, Graduate School of Medical and Dental Sciences, Kagoshima, Japan (GRID:grid.258333.c) (ISNI:0000 0001 1167 1801)
2 Research and Development Department, Japan BCG Laboratory, Tokyo, Japan (GRID:grid.452610.4) (ISNI:0000 0004 1758 6116)
3 Biomedical Laboratory, Division of Biomedical Research, Kitasato University Medical Center, Kitamoto, Japan (GRID:grid.415399.3)
4 Division of Molecular and Cellular Immunoscience, Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan (GRID:grid.412339.e) (ISNI:0000 0001 1172 4459)
5 Kagoshima University, Department of Hygiene and Health Promotion Medicine, Graduate School of Medical and Dental Sciences, Kagoshima, Japan (GRID:grid.258333.c) (ISNI:0000 0001 1167 1801)
6 Tropical Biosphere Research Center, University of the Ryukyus, Nishihara, Japan (GRID:grid.267625.2) (ISNI:0000 0001 0685 5104)
7 Kagoshima University, Department of Immunology, Graduate School of Medical and Dental Sciences, Kagoshima, Japan (GRID:grid.258333.c) (ISNI:0000 0001 1167 1801); Osaka University, Department of Molecular Immunology, Division of Host Defense, Research Institute for Microbial Disease, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)
8 Research and Development Department, Japan BCG Laboratory, Tokyo, Japan (GRID:grid.452610.4) (ISNI:0000 0004 1758 6116); Faculty of Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan (GRID:grid.261445.0) (ISNI:0000 0001 1009 6411)
9 BJC Institute of Health at Washington University, Department of Pathology and Immunology, St. Louis, USA (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
10 Laboratory of Cell Regulation, Institute for Virus Research, Graduate School of Biostudies, Kyoto University, Kyoto, Japan (GRID:grid.258799.8) (ISNI:0000 0004 0372 2033)
11 Osaka University, Department of Molecular Immunology, Division of Host Defense, Research Institute for Microbial Disease, Osaka, Japan (GRID:grid.136593.b) (ISNI:0000 0004 0373 3971)